• Explore /
  • Poster
  • / <span>Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.</span>

Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.

Abstract Poster

Authors

null

Jacob Kaufman

The James Cancer Hospital and Solove Research Institute, Columbus, OH

Jacob Kaufman , Dwight Hall Owen , Regan Michelle Memmott , Gregory Alan Otterson , Kai He , Carolyn J Presley , Daniel Spakowicz , Peter G. Shields , Xiaoli Zhang , Theresa A. Boyle , W. Douglas Cress , Kris Wood , Neal E. Ready , Lang Li , Zihai Li , David Paul Carbone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2626)

DOI

10.1200/JCO.2023.41.16_suppl.2626

Abstract #

2626

Poster Bd #

468

Abstract Disclosures

Similar Posters

First Author: Alessio Cortellini

Poster

2024 ASCO Annual Meeting

<span fontscheme="2">Comprehensive characterization of </span><em fontscheme="2">ERBB2</em><span fontscheme="2"> genomic alterations in</span><em fontscheme="2"> </em><span fontscheme="2">lung cancer.</span>

Comprehensive characterization of ERBB2 genomic alterations in lung cancer.

First Author: Talal El Zarif

First Author: Sukhmani Kaur Padda

First Author: Brian Warnecke